© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans
Affiliation of authors: Fred Hutchinson Cancer Research Center, Seattle, WA (DAG, JJC).
Correspondence to: Denise A. Galloway, PhD, Program Head of Cancer Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Rm. C-105, Seattle, WA 98109-1024 (e-mail: dgallowa@fhcrc.org)
| The first 10% of the full text of this article appears below. |
We thank Barbanti-Brodano et al. for their interest in our recent manuscript (1). We set out to examine the hypothesis that antibodies to simian virus 40 (SV40) would be prevalent in the population; given that so many tumor sites have been reported to harbor SV40 DNA, even in individuals too young to have been exposed to SV40, one prediction would be that SV40 is a
Correspondence about this Article
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 806-807.